A detailed history of Able Financial Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Able Financial Group, LLC holds 645 shares of AMGN stock, worth $169,751. This represents 0.06% of its overall portfolio holdings.

Number of Shares
645
Previous 645 -0.0%
Holding current value
$169,751
Previous $201 Million 3.14%
% of portfolio
0.06%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $169,473 - $205,954
645 New
645 $201 Million
Q4 2023

Jan 24, 2024

BUY
$255.7 - $288.46 $195,866 - $220,960
766 New
766 $221 Million
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $8,785 - $10,388
41 Added 4.43%
967 $215 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $209,081 - $254,835
926 New
926 $224 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Able Financial Group, LLC Portfolio

Follow Able Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Able Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Able Financial Group, LLC with notifications on news.